IS7674A - Kristal form af kínoxalín-2-karboxýlsýru [4-karbamóýl-1-(3-flúrbensýl)-2,7-díhýdroxý-7-metýl-oktýl]-amíði - Google Patents

Kristal form af kínoxalín-2-karboxýlsýru [4-karbamóýl-1-(3-flúrbensýl)-2,7-díhýdroxý-7-metýl-oktýl]-amíði

Info

Publication number: IS7674A
Authority: IS; Iceland
Prior art keywords: fluorobenzyl; quinoxaline; carbamoyl; dihydroxy; octyl
Prior art date: 2002-08-12

Application number

IS7674A

Other languages

English (en)

Inventor

Charles Kath John

Jane Li Zheng

Bryan Li Zhengong

Brock Mcelroy Eric

Nathaniel Meltz Clifford

Stanley Poss Christopher

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-12

Filing date

2005-01-27

Publication date

2005-01-27

2005-01-27 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2005-01-27 Publication of IS7674A publication Critical patent/IS7674A/is

Links

239000013078 crystal Substances 0.000 title 1
YEQJVHQCUDMXFG-UHFFFAOYSA-N n-[5-carbamoyl-1-(3-fluorophenyl)-3,8-dihydroxy-8-methylnonan-2-yl]quinoxaline-2-carboxamide Chemical compound C=1N=C2C=CC=CC2=NC=1C(=O)NC(C(O)CC(CCC(C)(O)C)C(N)=O)CC1=CC=CC(F)=C1 YEQJVHQCUDMXFG-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
AIDS & HIV (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Tropical Medicine & Parasitology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Plural Heterocyclic Compounds (AREA)

IS7674A 2002-08-12 2005-01-27 Kristal form af kínoxalín-2-karboxýlsýru [4-karbamóýl-1-(3-flúrbensýl)-2,7-díhýdroxý-7-metýl-oktýl]-amíði IS7674A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US40321602P	2002-08-12	2002-08-12
PCT/IB2003/003464 WO2004014875A1 (en)	2002-08-12	2003-07-31	Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide

Publications (1)

Publication Number	Publication Date
IS7674A true IS7674A (is)	2005-01-27

Family

ID=31715961

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7674A IS7674A (is)	2002-08-12	2005-01-27	Kristal form af kínoxalín-2-karboxýlsýru [4-karbamóýl-1-(3-flúrbensýl)-2,7-díhýdroxý-7-metýl-oktýl]-amíði

Country Status (22)

Country	Link
US (1)	US20040072834A1 (is)
EP (1)	EP1539715A1 (is)
JP (1)	JP2005538130A (is)
AP (1)	AP2005003226A0 (is)
AR (1)	AR040839A1 (is)
AU (1)	AU2003250450A1 (is)
BR (1)	BR0313378A (is)
CA (1)	CA2494776A1 (is)
EC (1)	ECSP055588A (is)
GT (1)	GT200300169A (is)
IL (1)	IL166548A0 (is)
IS (1)	IS7674A (is)
MX (1)	MXPA05001781A (is)
NO (1)	NO20050540L (is)
OA (1)	OA12894A (is)
PA (1)	PA8580401A1 (is)
PE (1)	PE20040866A1 (is)
TN (1)	TNSN05035A1 (is)
TW (1)	TW200407316A (is)
UY (1)	UY27928A1 (is)
WO (1)	WO2004014875A1 (is)
ZA (1)	ZA200500768B (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5731538B2 (ja)	2009-12-23	2015-06-10	アイアンウッドファーマシューティカルズインコーポレイテッド	Ｃｒｔｈ２モジュレーター
WO2012009137A1 (en)	2010-07-12	2012-01-19	Ironwood Pharmaceuticals, Inc.	Crth2 modulators
US20130259830A1 (en)	2010-07-12	2013-10-03	Ironwood Pharmaceuticals, Inc.	Crth2 modulators
CN102276539B (zh) *	2011-06-29	2013-08-14	赵雪梅	一种具有抑菌作用的化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE640616A (is) *	1962-12-19
US3492397A (en) *	1967-04-07	1970-01-27	Warner Lambert Pharmaceutical	Sustained release dosage in the pellet form and process thereof
US4060598A (en) *	1967-06-28	1977-11-29	Boehringer Mannheim G.M.B.H.	Tablets coated with aqueous resin dispersions
US3538214A (en) *	1969-04-22	1970-11-03	Merck & Co Inc	Controlled release medicinal tablets
US4173626A (en) *	1978-12-11	1979-11-06	Merck & Co., Inc.	Sustained release indomethacin
WO1998038167A1 (en) *	1997-02-26	1998-09-03	Pfizer Inc.	Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
UA57824C2 (uk) *	1998-02-05	2003-07-15	Пфайзер Продактс Інк.	Похідні дигідроксигексанової кислоти, фармацевтична композиція, що їх містить (варіанти), та спосіб лікування (варіанти)

2003
- 2003-07-31 WO PCT/IB2003/003464 patent/WO2004014875A1/en not_active Ceased
- 2003-07-31 AP AP2005003226A patent/AP2005003226A0/xx unknown
- 2003-07-31 CA CA002494776A patent/CA2494776A1/en not_active Abandoned
- 2003-07-31 OA OA1200500028A patent/OA12894A/en unknown
- 2003-07-31 MX MXPA05001781A patent/MXPA05001781A/es not_active Application Discontinuation
- 2003-07-31 JP JP2004527195A patent/JP2005538130A/ja active Pending
- 2003-07-31 BR BR0313378-8A patent/BR0313378A/pt not_active Application Discontinuation
- 2003-07-31 AU AU2003250450A patent/AU2003250450A1/en not_active Abandoned
- 2003-07-31 EP EP03784383A patent/EP1539715A1/en not_active Withdrawn
- 2003-08-05 UY UY27928A patent/UY27928A1/es not_active Application Discontinuation
- 2003-08-06 GT GT200300169A patent/GT200300169A/es unknown
- 2003-08-06 TW TW092121503A patent/TW200407316A/zh unknown
- 2003-08-08 US US10/637,475 patent/US20040072834A1/en not_active Abandoned
- 2003-08-08 AR AR20030102881A patent/AR040839A1/es unknown
- 2003-08-08 PE PE2003000794A patent/PE20040866A1/es not_active Application Discontinuation
- 2003-08-12 PA PA20038580401A patent/PA8580401A1/es unknown
2005
- 2005-01-26 ZA ZA200500768A patent/ZA200500768B/xx unknown
- 2005-01-27 IL IL16654805A patent/IL166548A0/xx unknown
- 2005-01-27 IS IS7674A patent/IS7674A/is unknown
- 2005-01-31 NO NO20050540A patent/NO20050540L/no unknown
- 2005-02-03 EC EC2005005588A patent/ECSP055588A/es unknown
- 2005-02-11 TN TNP2005000035A patent/TNSN05035A1/fr unknown

Also Published As

Publication number	Publication date
TW200407316A (en)	2004-05-16
ECSP055588A (es)	2005-04-18
ZA200500768B (en)	2006-07-26
AP2005003226A0 (en)	2005-03-31
JP2005538130A (ja)	2005-12-15
BR0313378A (pt)	2005-07-12
UY27928A1 (es)	2004-03-31
NO20050540L (no)	2005-03-10
OA12894A (en)	2006-10-13
PA8580401A1 (es)	2004-02-16
CA2494776A1 (en)	2004-02-19
WO2004014875A1 (en)	2004-02-19
US20040072834A1 (en)	2004-04-15
GT200300169A (es)	2004-05-12
MXPA05001781A (es)	2005-04-25
PE20040866A1 (es)	2004-11-26
IL166548A0 (en)	2006-01-15
EP1539715A1 (en)	2005-06-15
AR040839A1 (es)	2005-04-20
AU2003250450A1 (en)	2004-02-25
TNSN05035A1 (fr)	2007-05-14

Publication	Publication Date	Title
EP1674473A4 (en)	2008-12-17	Photoacid generator
DE602004025759D1 (de)	2010-04-15	Synchronisierung von Datenkommunikation
DK1490064T3 (da)	2010-01-04	Substituerede pyridinoner som modulatorer af p38 MAP kinase
FI20020677A0 (fi)	2002-04-09	Pakettidatan siirtäminen langattomaan päätelaitteeseen
DK2508521T4 (da)	2022-10-03	Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf
DK1438306T3 (da)	2014-06-23	Derivater af UK-2A
NO20053041D0 (no)	2005-06-21	Behandling av diabetes.
SI3281939T1 (sl)	2024-02-29	Kombinacija, ki obsega stabilni kristal 4-oksokinolinske spojine
DK1529032T3 (da)	2013-07-08	Fremgangsmåder til fremstilling af 4-4-4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)aminobenzonitrill
DK1592401T3 (da)	2012-05-21	Fremgangsmåde til ændring af medikamentkrystaldannelsen af mycophenolat-natriumsalt
DK1309545T3 (da)	2007-10-29	Fremgangsmåde til fremstilling af alkylarylsulfonater
DE602004028075D1 (de)	2010-08-26	Endgerät mit Auflösung von Betriebsmittelkonflikten
DK1546122T3 (da)	2008-03-03	Fremgangsmåde til fremstilling af valsartan
IS6954A (is)	2003-09-15	Notkun á enantíómerískt hreinu essítalóprami
DE60334261D1 (de)	2010-11-04	Internet basierte Verwaltung von Bildersammlungen
DE60216641D1 (de)	2007-01-18	Polymorph von 4-ä2-ä4-ä1-(2-ethoxyethyl)-1h-benzimidazol-2-ylü-1-piperidinylüethylü-alpha, alpha-dimethylbenzolessigsäure
DK1353923T3 (da)	2005-01-31	Forbedret fremgangsmåde til syntese af carbapenem
DE602005024336D1 (de)	2010-12-09	Sendung von Nachbarnzellinformationen
DK1519928T3 (da)	2014-08-04	Fremgangsmåde til fremstilling af heterocykliske fluoralkenylsulfoner
DK1575941T3 (da)	2012-07-09	Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1505992T3 (da)	2008-10-06	Fremgangsmåde til reduktion af smerter ved hjælp af oncolytiske vira
IS7674A (is)	2005-01-27	Kristal form af kínoxalín-2-karboxýlsýru [4-karbamóýl-1-(3-flúrbensýl)-2,7-díhýdroxý-7-metýl-oktýl]-amíði
DE602004027975D1 (de)	2010-08-19	Herstellungsverfahren von Elektrodenpaste
DE60326321D1 (de)	2009-04-09	Herstellungsverfahren von Farbstoffen
DK1519936T3 (da)	2008-03-03	Fremgangsmåde til fremstilling af nevirapin